Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Indivior Pharmaceuticals (INDV) Inventory Average (2023 - 2025)

Historic Inventory Average for Indivior Pharmaceuticals (INDV) over the last 3 years, with Q3 2025 value amounting to $152.0 million.

  • Indivior Pharmaceuticals' Inventory Average fell 1289.4% to $152.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $152.0 million, marking a year-over-year decrease of 1289.4%. This contributed to the annual value of $146.5 million for FY2024, which is 2208.33% up from last year.
  • Latest data reveals that Indivior Pharmaceuticals reported Inventory Average of $152.0 million as of Q3 2025, which was down 1289.4% from $156.0 million recorded in Q2 2025.
  • Indivior Pharmaceuticals' 5-year Inventory Average high stood at $174.5 million for Q3 2024, and its period low was $134.0 million during Q4 2023.
  • Over the past 3 years, Indivior Pharmaceuticals' median Inventory Average value was $156.0 million (recorded in 2025), while the average stood at $155.8 million.
  • As far as peak fluctuations go, Indivior Pharmaceuticals' Inventory Average soared by 2873.13% in 2024, and later tumbled by 1289.4% in 2025.
  • Indivior Pharmaceuticals' Inventory Average (Quarter) stood at $134.0 million in 2023, then rose by 28.73% to $172.5 million in 2024, then fell by 11.88% to $152.0 million in 2025.
  • Its last three reported values are $152.0 million in Q3 2025, $156.0 million for Q2 2025, and $165.0 million during Q1 2025.